Cargando…
Abnormalities by Multicolor Flow Cytometry for Detection of Minimal Residual Disease in Recipients of Allo-HSCT Originating from Donors: A Cohort Study
OBJECTIVE: In minimal residual disease (MRD) analysis after allogeneic hematopoietic stem cell transplantation (allo-HSCT), abnormal immunophenotyping is commonly considered as evidence of a secondary recurrence or complications, leading to overtreatment. We aimed to confirm whether such phenotypic...
Autores principales: | Wang, Hui, Wang, Aixian, Chen, Man, Gong, Meiwei, Wu, Xueying, Zhen, Junyi, Lu, Yue |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Galenos Publishing
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9979734/ https://www.ncbi.nlm.nih.gov/pubmed/36718627 http://dx.doi.org/10.4274/tjh.galenos.2022.2022.0365 |
Ejemplares similares
-
Twenty-four-color full spectrum flow cytometry panel for minimal residual disease detection in acute myeloid leukemia
por: Chen, Man, et al.
Publicado: (2023) -
PD-1 and CTLA-4 up regulation on donor T cells is insufficient to prevent GvHD in allo-HSCT recipients
por: Hossain, Mohammad S., et al.
Publicado: (2017) -
PB2208: CAR-T TREATMENT POST FIRST ALLO-HSCT FAILURE MAY HAVE DIFFERENT PROCESSION COMPARING TO CAR-T BEFORE ALLO-HSCT
por: wang, D., et al.
Publicado: (2022) -
Minimal residual disease detection by multicolor flow cytometry in cryopreserved ovarian tissue from leukemia patients
por: Zver, Tristan, et al.
Publicado: (2022) -
Biological and Genetic Aspects of Donor-Recipient Matching in HSCT
por: Lange, Andrzej, et al.
Publicado: (2012)